|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/711 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 47/10 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Patento numeris | 2444065 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11180358.1 |
| Europos patento paraiškos padavimo data | 2007-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 556503 | 2006-11-03 | US |
| (72) |
Trogden, John T., US
Lyons, Robert T., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |